Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Pharmaceutical intermediates >  Heterocyclic compound >  Pyran compounds >  4-Cyanotetrahydro-4H-pyran

4-Cyanotetrahydro-4H-pyran

Basic information Safety Supplier Related

4-Cyanotetrahydro-4H-pyran Basic information

Product Name:
4-Cyanotetrahydro-4H-pyran
Synonyms:
  • 4-CYANOTETRAHYDRO-4H-PYRAN
  • 4-Cyanotetrahydropyran
  • tetrahydro-2H-pyran-4-carbonitrile(SALTDATA: FREE)
  • Tetrahydro-pyran-4-carbonitrile
  • 4-cyanotetrahydropiran
  • oxane-4-carbonitrile
  • 2H-Pyran-4-carbonitrile, tetrahydro-
  • 4-Cyanotetrahydro-4H-pyran manufacturer
CAS:
4295-99-2
MF:
C6H9NO
MW:
111.14
Mol File:
4295-99-2.mol
More
Less

4-Cyanotetrahydro-4H-pyran Chemical Properties

Boiling point:
82-83 °C(Press: 10 Torr)
Density 
1.0343 g/cm3
refractive index 
1.4521
storage temp. 
2-8°C
Appearance
Colorless to light yellow Liquid
InChI
InChI=1S/C6H9NO/c7-5-6-1-3-8-4-2-6/h6H,1-4H2
InChIKey
RLZJFTOYCVIYLE-UHFFFAOYSA-N
SMILES
C1OCCC(C#N)C1
More
Less

Safety Information

RIDADR 
UN2811
HazardClass 
IRRITANT
HS Code 
2932990090
More
Less

4-Cyanotetrahydro-4H-pyran Usage And Synthesis

Uses

Tetrahydro-2H-Pyran-4-Carbonitrile is used in preparation of substituted Amide compounds as farnesoid X receptor modulators.

Synthesis

344329-76-6

4295-99-2

The general procedure for the synthesis of 4-cyanotetrahydropyran from tetrahydropyran-4-carboxamide was as follows: thionyl chloride (10.0 mL, 137 mmol) was slowly added to tetrahydropyran-4-carboxamide (3.0 g, 23 mmol), and the reaction mixture was stirred under reflux for 4 hr. Upon completion of the reaction, the mixture was carefully decanted onto ice and the pH was adjusted with 50% sodium hydroxide solution to 14. Subsequently, the aqueous phase was extracted with ethyl acetate (3 x 50 mL), the organic phases were combined and dried over anhydrous sodium sulfate. The organic phase was concentrated under reduced pressure to give a light yellow oily product (2.4 g, 94% yield) which did not require further purification. The structure of the product was confirmed by the following characterization data: IR (νmax, cm-1 ): 2961, 2932, 2851, 2240, 1468, 1446, 1390, 1242, 1125, 1066, 1011; 1H NMR (500 MHz, CDCl3): δ 3.91 (2H, ddd, J = 11.9, 6.3, 3.6 Hz, 2 × 3.6 Hz, 2 × 3.6 Hz, 2 × 3.9, 6.3, 3.6 Hz, 2 × 3.6 Hz). 3.6 Hz, 2×2-HA), 3.61 (2H, ddd, J = 11.9, 7.8, 3.3 Hz, 2×2-HB), 2.91-2.85 (1H, m, 4-H), 1.99-1.92 (2H, m, 2×3-HA), 1.91-1.84 (2H, m, 2×3-HB); 13C NMR (75 MHz, CDCl3): δ 121.2, 65.6, 28.9, 25.3; HRMS (ESI+): calculated value C6H10NO ([M+H]+): 112.0756, measured value: 112.0754, Δ -1.8 ppm.

References

[1] Bioorganic and Medicinal Chemistry, 2015, vol. 23, # 11, p. 2629 - 2635
[2] Patent: US2007/111984, 2007, A1. Location in patent: Page/Page column 45
[3] Journal of the American Chemical Society, 1943, vol. 65, p. 370
[4] Patent: US2009/253679, 2009, A1. Location in patent: Page/Page column 54-55

4-Cyanotetrahydro-4H-pyranSupplier

BTC Pharmaceutical CO. Ltd Gold
Tel
15716293042 18862996710
Email
15050603958@163.com
Jinan Kabotang Biological Technology Co.,Ltd. Gold
Tel
0531-61320525 15866703830
Email
figo.gao@foxmail.com
J & K SCIENTIFIC LTD.
Tel
18210857532; 18210857532
Email
jkinfo@jkchemical.com
ITIC MEDCHEM(SUZHOU) CO.,LTD.
Tel
0512-68323967 18015559028
Email
sales@iticmedchem.com
Energy Chemical
Tel
021-021-58432009 400-005-6266
Email
sales8178@energy-chemical.com